-+ 0.00%
-+ 0.00%
-+ 0.00%

DIAMYD MEDICAL ACCELERATES PRIMARY EFFICACY READOUT BY 9 MONTHS IN TYPE 1 DIABETES PHASE 3 TRIAL FOLLOWING FDA ALIGNMENT AND GUIDANCE

路透·12/29/2025 07:45:51

登錄查看新聞詳情